Alveolar bone regeneration using absorbable poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor.
Identifieur interne : 002043 ( Ncbi/Merge ); précédent : 002042; suivant : 002044Alveolar bone regeneration using absorbable poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor.
Auteurs : Y. Kinoshita [Japon] ; M. Matsuo ; K. Todoki ; S. Ozono ; S. Fukuoka ; H. Tsuzuki ; M. Nakamura ; K. Tomihata ; T. Shimamoto ; Y. IkadaSource :
- International journal of oral and maxillofacial surgery [ 0901-5027 ] ; 2008.
Descripteurs français
- KwdFr :
- Animaux, Chiens, Densité osseuse (physiologie), Facteur de croissance fibroblastique de type 2 (usage thérapeutique), Filet chirurgical, Hémostatiques (usage thérapeutique), Maladies mandibulaires (), Maladies mandibulaires (anatomopathologie), Maladies mandibulaires (physiopathologie), Mandibule (anatomopathologie), Mandibule (physiopathologie), Matériaux biocompatibles (), Membrane artificielle, Mâchoire édentée (), Mâchoire édentée (physiopathologie), Ostéogenèse (physiologie), Phosphates de calcium (), Polyesters (), Processus alvéolaire (anatomopathologie), Processus alvéolaire (physiopathologie), Régénération osseuse (physiologie), Régénération tissulaire guidée (), Résorption alvéolaire (), Résorption alvéolaire (anatomopathologie), Résorption alvéolaire (physiopathologie), Tomodensitométrie (), Éponge de gélatine résorbable (usage thérapeutique).
- MESH :
- anatomopathologie : Maladies mandibulaires, Mandibule, Processus alvéolaire, Résorption alvéolaire.
- physiologie : Densité osseuse, Ostéogenèse, Régénération osseuse.
- physiopathologie : Maladies mandibulaires, Mandibule, Mâchoire édentée, Processus alvéolaire, Résorption alvéolaire.
- usage thérapeutique : Facteur de croissance fibroblastique de type 2, Hémostatiques, Éponge de gélatine résorbable.
- Animaux, Chiens, Filet chirurgical, Maladies mandibulaires, Matériaux biocompatibles, Membrane artificielle, Mâchoire édentée, Phosphates de calcium, Polyesters, Régénération tissulaire guidée, Résorption alvéolaire, Tomodensitométrie.
English descriptors
- KwdEn :
- Alveolar Bone Loss (pathology), Alveolar Bone Loss (physiopathology), Alveolar Bone Loss (surgery), Alveolar Process (pathology), Alveolar Process (physiopathology), Animals, Biocompatible Materials (chemistry), Bone Density (physiology), Bone Regeneration (physiology), Calcium Phosphates (chemistry), Dogs, Fibroblast Growth Factor 2 (therapeutic use), Gelatin Sponge, Absorbable (therapeutic use), Guided Tissue Regeneration (methods), Hemostatics (therapeutic use), Jaw, Edentulous (physiopathology), Jaw, Edentulous (surgery), Mandible (pathology), Mandible (physiopathology), Mandibular Diseases (pathology), Mandibular Diseases (physiopathology), Mandibular Diseases (surgery), Membranes, Artificial, Osteogenesis (physiology), Polyesters (chemistry), Surgical Mesh, Tomography, X-Ray Computed (methods).
- MESH :
- chemical , chemistry : Biocompatible Materials, Calcium Phosphates, Polyesters.
- methods : Guided Tissue Regeneration, Tomography, X-Ray Computed.
- pathology : Alveolar Bone Loss, Alveolar Process, Mandible, Mandibular Diseases.
- physiology : Bone Density, Bone Regeneration, Osteogenesis.
- physiopathology : Alveolar Bone Loss, Alveolar Process, Jaw, Edentulous, Mandible, Mandibular Diseases.
- surgery : Alveolar Bone Loss, Jaw, Edentulous, Mandibular Diseases.
- chemical , therapeutic use : Fibroblast Growth Factor 2, Gelatin Sponge, Absorbable, Hemostatics.
- Animals, Dogs, Membranes, Artificial, Surgical Mesh.
Abstract
The aim of this study was to evaluate the effects of combining a porous poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblastic growth factor (bFGF) on bone regeneration in mandibular ridges. Four full-thickness saddle-type defects (10 mm long x 5 mm deep) were symmetrically created in both edentulous mandibular alveolar ridges of 6 beagles. The dome-shaped membrane was secured to each defect site, and a gelatin sponge containing 200 microg bFGF was implanted on the left side of each defect (experimental group). Only the membranes (control group) were secured to the defect sites on the right. Three and 6 months later, 3 animals were killed. Bone regeneration was analyzed by soft X-ray photographs, micro-computed tomography (CT) images, and peripheral quantitative CT (pQCT), and then examined histologically. Soft X-ray examination revealed an increase in new bone volume in the experimental group 6 months postoperatively. pQCT showed that immature bone density was higher in the experimental group. Micro-CT images revealed well formed new bone along the original contour of the dome-shaped membrane in the experimental group. Histologically, inflammatory infiltration of tissue surrounding the membranes was slight. These results suggest that combining the poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and bFGF-gelatin sponge is promising for alveolar ridge reconstruction.
DOI: 10.1016/j.ijom.2007.11.010
PubMed: 18262760
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002194
- to stream PubMed, to step Curation: 002194
- to stream PubMed, to step Checkpoint: 002194
Links to Exploration step
pubmed:18262760Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Alveolar bone regeneration using absorbable poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor.</title><author><name sortKey="Kinoshita, Y" sort="Kinoshita, Y" uniqKey="Kinoshita Y" first="Y" last="Kinoshita">Y. Kinoshita</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Frontier Oral Science, Kanagawa Dental College, Yokosuka, Kanagawa, Japan. kinoshit@kdcnet.ac.jp</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Institute for Frontier Oral Science, Kanagawa Dental College, Yokosuka, Kanagawa</wicri:regionArea><wicri:noRegion>Kanagawa</wicri:noRegion></affiliation></author><author><name sortKey="Matsuo, M" sort="Matsuo, M" uniqKey="Matsuo M" first="M" last="Matsuo">M. Matsuo</name></author><author><name sortKey="Todoki, K" sort="Todoki, K" uniqKey="Todoki K" first="K" last="Todoki">K. Todoki</name></author><author><name sortKey="Ozono, S" sort="Ozono, S" uniqKey="Ozono S" first="S" last="Ozono">S. Ozono</name></author><author><name sortKey="Fukuoka, S" sort="Fukuoka, S" uniqKey="Fukuoka S" first="S" last="Fukuoka">S. Fukuoka</name></author><author><name sortKey="Tsuzuki, H" sort="Tsuzuki, H" uniqKey="Tsuzuki H" first="H" last="Tsuzuki">H. Tsuzuki</name></author><author><name sortKey="Nakamura, M" sort="Nakamura, M" uniqKey="Nakamura M" first="M" last="Nakamura">M. Nakamura</name></author><author><name sortKey="Tomihata, K" sort="Tomihata, K" uniqKey="Tomihata K" first="K" last="Tomihata">K. Tomihata</name></author><author><name sortKey="Shimamoto, T" sort="Shimamoto, T" uniqKey="Shimamoto T" first="T" last="Shimamoto">T. Shimamoto</name></author><author><name sortKey="Ikada, Y" sort="Ikada, Y" uniqKey="Ikada Y" first="Y" last="Ikada">Y. Ikada</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:18262760</idno><idno type="pmid">18262760</idno><idno type="doi">10.1016/j.ijom.2007.11.010</idno><idno type="wicri:Area/PubMed/Corpus">002194</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002194</idno><idno type="wicri:Area/PubMed/Curation">002194</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002194</idno><idno type="wicri:Area/PubMed/Checkpoint">002194</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002194</idno><idno type="wicri:Area/Ncbi/Merge">002043</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Alveolar bone regeneration using absorbable poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor.</title><author><name sortKey="Kinoshita, Y" sort="Kinoshita, Y" uniqKey="Kinoshita Y" first="Y" last="Kinoshita">Y. Kinoshita</name><affiliation wicri:level="1"><nlm:affiliation>Institute for Frontier Oral Science, Kanagawa Dental College, Yokosuka, Kanagawa, Japan. kinoshit@kdcnet.ac.jp</nlm:affiliation><country xml:lang="fr">Japon</country><wicri:regionArea>Institute for Frontier Oral Science, Kanagawa Dental College, Yokosuka, Kanagawa</wicri:regionArea><wicri:noRegion>Kanagawa</wicri:noRegion></affiliation></author><author><name sortKey="Matsuo, M" sort="Matsuo, M" uniqKey="Matsuo M" first="M" last="Matsuo">M. Matsuo</name></author><author><name sortKey="Todoki, K" sort="Todoki, K" uniqKey="Todoki K" first="K" last="Todoki">K. Todoki</name></author><author><name sortKey="Ozono, S" sort="Ozono, S" uniqKey="Ozono S" first="S" last="Ozono">S. Ozono</name></author><author><name sortKey="Fukuoka, S" sort="Fukuoka, S" uniqKey="Fukuoka S" first="S" last="Fukuoka">S. Fukuoka</name></author><author><name sortKey="Tsuzuki, H" sort="Tsuzuki, H" uniqKey="Tsuzuki H" first="H" last="Tsuzuki">H. Tsuzuki</name></author><author><name sortKey="Nakamura, M" sort="Nakamura, M" uniqKey="Nakamura M" first="M" last="Nakamura">M. Nakamura</name></author><author><name sortKey="Tomihata, K" sort="Tomihata, K" uniqKey="Tomihata K" first="K" last="Tomihata">K. Tomihata</name></author><author><name sortKey="Shimamoto, T" sort="Shimamoto, T" uniqKey="Shimamoto T" first="T" last="Shimamoto">T. Shimamoto</name></author><author><name sortKey="Ikada, Y" sort="Ikada, Y" uniqKey="Ikada Y" first="Y" last="Ikada">Y. Ikada</name></author></analytic><series><title level="j">International journal of oral and maxillofacial surgery</title><idno type="ISSN">0901-5027</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alveolar Bone Loss (pathology)</term><term>Alveolar Bone Loss (physiopathology)</term><term>Alveolar Bone Loss (surgery)</term><term>Alveolar Process (pathology)</term><term>Alveolar Process (physiopathology)</term><term>Animals</term><term>Biocompatible Materials (chemistry)</term><term>Bone Density (physiology)</term><term>Bone Regeneration (physiology)</term><term>Calcium Phosphates (chemistry)</term><term>Dogs</term><term>Fibroblast Growth Factor 2 (therapeutic use)</term><term>Gelatin Sponge, Absorbable (therapeutic use)</term><term>Guided Tissue Regeneration (methods)</term><term>Hemostatics (therapeutic use)</term><term>Jaw, Edentulous (physiopathology)</term><term>Jaw, Edentulous (surgery)</term><term>Mandible (pathology)</term><term>Mandible (physiopathology)</term><term>Mandibular Diseases (pathology)</term><term>Mandibular Diseases (physiopathology)</term><term>Mandibular Diseases (surgery)</term><term>Membranes, Artificial</term><term>Osteogenesis (physiology)</term><term>Polyesters (chemistry)</term><term>Surgical Mesh</term><term>Tomography, X-Ray Computed (methods)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Chiens</term><term>Densité osseuse (physiologie)</term><term>Facteur de croissance fibroblastique de type 2 (usage thérapeutique)</term><term>Filet chirurgical</term><term>Hémostatiques (usage thérapeutique)</term><term>Maladies mandibulaires ()</term><term>Maladies mandibulaires (anatomopathologie)</term><term>Maladies mandibulaires (physiopathologie)</term><term>Mandibule (anatomopathologie)</term><term>Mandibule (physiopathologie)</term><term>Matériaux biocompatibles ()</term><term>Membrane artificielle</term><term>Mâchoire édentée ()</term><term>Mâchoire édentée (physiopathologie)</term><term>Ostéogenèse (physiologie)</term><term>Phosphates de calcium ()</term><term>Polyesters ()</term><term>Processus alvéolaire (anatomopathologie)</term><term>Processus alvéolaire (physiopathologie)</term><term>Régénération osseuse (physiologie)</term><term>Régénération tissulaire guidée ()</term><term>Résorption alvéolaire ()</term><term>Résorption alvéolaire (anatomopathologie)</term><term>Résorption alvéolaire (physiopathologie)</term><term>Tomodensitométrie ()</term><term>Éponge de gélatine résorbable (usage thérapeutique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Biocompatible Materials</term><term>Calcium Phosphates</term><term>Polyesters</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Maladies mandibulaires</term><term>Mandibule</term><term>Processus alvéolaire</term><term>Résorption alvéolaire</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Guided Tissue Regeneration</term><term>Tomography, X-Ray Computed</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Alveolar Bone Loss</term><term>Alveolar Process</term><term>Mandible</term><term>Mandibular Diseases</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Densité osseuse</term><term>Ostéogenèse</term><term>Régénération osseuse</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Bone Density</term><term>Bone Regeneration</term><term>Osteogenesis</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Maladies mandibulaires</term><term>Mandibule</term><term>Mâchoire édentée</term><term>Processus alvéolaire</term><term>Résorption alvéolaire</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Alveolar Bone Loss</term><term>Alveolar Process</term><term>Jaw, Edentulous</term><term>Mandible</term><term>Mandibular Diseases</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Alveolar Bone Loss</term><term>Jaw, Edentulous</term><term>Mandibular Diseases</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Fibroblast Growth Factor 2</term><term>Gelatin Sponge, Absorbable</term><term>Hemostatics</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Facteur de croissance fibroblastique de type 2</term><term>Hémostatiques</term><term>Éponge de gélatine résorbable</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Dogs</term><term>Membranes, Artificial</term><term>Surgical Mesh</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Chiens</term><term>Filet chirurgical</term><term>Maladies mandibulaires</term><term>Matériaux biocompatibles</term><term>Membrane artificielle</term><term>Mâchoire édentée</term><term>Phosphates de calcium</term><term>Polyesters</term><term>Régénération tissulaire guidée</term><term>Résorption alvéolaire</term><term>Tomodensitométrie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of this study was to evaluate the effects of combining a porous poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblastic growth factor (bFGF) on bone regeneration in mandibular ridges. Four full-thickness saddle-type defects (10 mm long x 5 mm deep) were symmetrically created in both edentulous mandibular alveolar ridges of 6 beagles. The dome-shaped membrane was secured to each defect site, and a gelatin sponge containing 200 microg bFGF was implanted on the left side of each defect (experimental group). Only the membranes (control group) were secured to the defect sites on the right. Three and 6 months later, 3 animals were killed. Bone regeneration was analyzed by soft X-ray photographs, micro-computed tomography (CT) images, and peripheral quantitative CT (pQCT), and then examined histologically. Soft X-ray examination revealed an increase in new bone volume in the experimental group 6 months postoperatively. pQCT showed that immature bone density was higher in the experimental group. Micro-CT images revealed well formed new bone along the original contour of the dome-shaped membrane in the experimental group. Histologically, inflammatory infiltration of tissue surrounding the membranes was slight. These results suggest that combining the poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and bFGF-gelatin sponge is promising for alveolar ridge reconstruction.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18262760</PMID><DateCompleted><Year>2008</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2008</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0901-5027</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>3</Issue><PubDate><Year>2008</Year><Month>Mar</Month></PubDate></JournalIssue><Title>International journal of oral and maxillofacial surgery</Title><ISOAbbreviation>Int J Oral Maxillofac Surg</ISOAbbreviation></Journal><ArticleTitle>Alveolar bone regeneration using absorbable poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor.</ArticleTitle><Pagination><MedlinePgn>275-81</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijom.2007.11.010</ELocationID><Abstract><AbstractText>The aim of this study was to evaluate the effects of combining a porous poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblastic growth factor (bFGF) on bone regeneration in mandibular ridges. Four full-thickness saddle-type defects (10 mm long x 5 mm deep) were symmetrically created in both edentulous mandibular alveolar ridges of 6 beagles. The dome-shaped membrane was secured to each defect site, and a gelatin sponge containing 200 microg bFGF was implanted on the left side of each defect (experimental group). Only the membranes (control group) were secured to the defect sites on the right. Three and 6 months later, 3 animals were killed. Bone regeneration was analyzed by soft X-ray photographs, micro-computed tomography (CT) images, and peripheral quantitative CT (pQCT), and then examined histologically. Soft X-ray examination revealed an increase in new bone volume in the experimental group 6 months postoperatively. pQCT showed that immature bone density was higher in the experimental group. Micro-CT images revealed well formed new bone along the original contour of the dome-shaped membrane in the experimental group. Histologically, inflammatory infiltration of tissue surrounding the membranes was slight. These results suggest that combining the poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and bFGF-gelatin sponge is promising for alveolar ridge reconstruction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinoshita</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Frontier Oral Science, Kanagawa Dental College, Yokosuka, Kanagawa, Japan. kinoshit@kdcnet.ac.jp</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuo</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Todoki</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Ozono</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Fukuoka</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tsuzuki</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Tomihata</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Shimamoto</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Ikada</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Int J Oral Maxillofac Surg</MedlineTA><NlmUniqueID>8605826</NlmUniqueID><ISSNLinking>0901-5027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001672">Biocompatible Materials</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002130">Calcium Phosphates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006490">Hemostatics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008567">Membranes, Artificial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011091">Polyesters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C471130">beta-tricalcium phosphate-poly-L-lactide copolymer</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C523703">poly(L-lactide-co-glycolide-co-epsilon-caprolactone)</NameOfSubstance></Chemical><Chemical><RegistryNumber>103107-01-3</RegistryNumber><NameOfSubstance UI="D016222">Fibroblast Growth Factor 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016301" MajorTopicYN="N">Alveolar Bone Loss</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000539" MajorTopicYN="N">Alveolar Process</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001672" MajorTopicYN="Y">Biocompatible Materials</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="N">Bone Density</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001861" MajorTopicYN="N">Bone Regeneration</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002130" MajorTopicYN="Y">Calcium Phosphates</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016222" MajorTopicYN="N">Fibroblast Growth Factor 2</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005781" MajorTopicYN="N">Gelatin Sponge, Absorbable</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048091" MajorTopicYN="N">Guided Tissue Regeneration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006490" MajorTopicYN="N">Hemostatics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007575" MajorTopicYN="N">Jaw, Edentulous</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008334" MajorTopicYN="N">Mandible</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008336" MajorTopicYN="N">Mandibular Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008567" MajorTopicYN="Y">Membranes, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010012" MajorTopicYN="N">Osteogenesis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011091" MajorTopicYN="Y">Polyesters</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013526" MajorTopicYN="N">Surgical Mesh</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="N">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year><Month>03</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2007</Year><Month>08</Month><Day>06</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>2</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>8</Month><Day>1</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>2</Month><Day>12</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18262760</ArticleId><ArticleId IdType="pii">S0901-5027(07)01064-8</ArticleId><ArticleId IdType="doi">10.1016/j.ijom.2007.11.010</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Japon</li></country></list><tree><noCountry><name sortKey="Fukuoka, S" sort="Fukuoka, S" uniqKey="Fukuoka S" first="S" last="Fukuoka">S. Fukuoka</name><name sortKey="Ikada, Y" sort="Ikada, Y" uniqKey="Ikada Y" first="Y" last="Ikada">Y. Ikada</name><name sortKey="Matsuo, M" sort="Matsuo, M" uniqKey="Matsuo M" first="M" last="Matsuo">M. Matsuo</name><name sortKey="Nakamura, M" sort="Nakamura, M" uniqKey="Nakamura M" first="M" last="Nakamura">M. Nakamura</name><name sortKey="Ozono, S" sort="Ozono, S" uniqKey="Ozono S" first="S" last="Ozono">S. Ozono</name><name sortKey="Shimamoto, T" sort="Shimamoto, T" uniqKey="Shimamoto T" first="T" last="Shimamoto">T. Shimamoto</name><name sortKey="Todoki, K" sort="Todoki, K" uniqKey="Todoki K" first="K" last="Todoki">K. Todoki</name><name sortKey="Tomihata, K" sort="Tomihata, K" uniqKey="Tomihata K" first="K" last="Tomihata">K. Tomihata</name><name sortKey="Tsuzuki, H" sort="Tsuzuki, H" uniqKey="Tsuzuki H" first="H" last="Tsuzuki">H. Tsuzuki</name></noCountry><country name="Japon"><noRegion><name sortKey="Kinoshita, Y" sort="Kinoshita, Y" uniqKey="Kinoshita Y" first="Y" last="Kinoshita">Y. Kinoshita</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002043 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002043 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:18262760
|texte= Alveolar bone regeneration using absorbable poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:18262760" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |